Investigation of the First Seven Reported Cases of Candida auris, a Globally Emerging Invasive, Multidrug-Resistant Fungus — United States, May 2013–August 2016

• Published in: MMWR. Morbidity and mortality weekly report Vol. 65; no. 44; pp. 1234 - 1237
• Main Authors: Vallabhaneni, Snigdha, Kallen, Alex, Tsay, Sharon, Chow, Nancy, Welsh, Rory, Kerins, Janna, Kemble, Sarah K., Pacilli, Massimo, Black, Stephanie R., Landon, Emily, Ridgway, Jessica, Palmore, Tara N., Zelzany, Adrian, Adams, Eleanor H., Quinn, Monica, Chaturvedi, Sudha, Greenko, Jane, Fernandez, Rafael, Southwick, Karen, Furuya, E. Yoko, Calfee, David P., Hamula, Camille, Patel, Gopi, Barrett, Patricia, Lafaro, Patricia, Berkow, Elizabeth L., Moulton-Meissner, Heather, Noble-Wang, Judith, Fagan, Ryan P., Jackson, Brendan R., Lockhart, Shawn R., Litvintseva, Anastasia P., Chiller, Tom M.
• Format: Journal Article Newsletter
• Language: English
• Published: United States Center for Surveillance, Epidemiology, and Laboratory Services, Centers for Disease Control and Prevention (CDC), U.S. Department of Health and Human Services 11.11.2016; U.S. Government Printing Office
• Subjects: Antifungal agents; Antifungal Agents - pharmacology; Antifungal Agents - therapeutic use; Candida; Candida - drug effects; Candida - isolation & purification; Candidiasis - diagnosis; Candidiasis - drug therapy; Candidiasis - microbiology; Communicable Diseases, Emerging; Drug Resistance, Multiple, Fungal; Fatal Outcome; Fungi; Global Health; Health aspects; Humans; Infection; Investigations; Medical schools; Microbial drug resistance; United States; New York; Maryland; Illinois; New Jersey

Candida auris, an emerging fungus that can cause invasive infections, is associated with high mortality and is often resistant to multiple antifungal drugs. C. auris was first described in 2009 after being isolated from external ear canal discharge of a patient in Japan (1). Since then, reports of C...